Europe Approves Bronchodilator Oxis Turbohaler (Eformoterol) For Children Six Years and Older
LONDON, ENGLAND — April 30, 2002 — New treatment option for exercise-induced asthma licensed in the UK AstraZeneca UK Ltd announced today that its long-acting
